CD8A and neoplasm: Consequently, there is an enhanced anti-tumor immune response, characterized by macrophage polarization, reduced suppressor cell populations, and restored CD8+ T cell infiltration, thereby increasing the efficacy of immunotherapies like anti-PD-L1 without causing systemic toxicities [61].